The COVID-19 omicron variant has diminished the efficacy of the US's most prominent antibody treatments. As the genome of this virus constantly…
McAlinden Research PartnersJanuary 4, 2022
New research on CRISPR techniques that could provide treatments and improved diagnostics for several major viruses and other medical conditions…
McAlinden Research PartnersNovember 13, 2019
The prevalence of chronic diseases combined with their sky-high price tags is drawing interest to digital therapeutics (DTx), a new…
McAlinden Research PartnersOctober 21, 2019
